We also find that trNK may also recruit CD4+ Tregs via IL-16 but concomitant FAS signaling would lead to Treg apoptosis and support tumor control (Figure 6D, Figure 7—figure supplement 1). The gene discussed is IL16; the disease is neoplasm.